世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

次世代シーケンスキット市場 - 世界の産業規模、シェア、動向、機会、および予測、2018-2028F ワークフロー別(ライブラリー調製、クラスター生成、シーケンス試薬キット)、シーケンスタイプ別(WESおよびWGS、ターゲットシーケンス、ロングリードシーケンス、その他のシーケンス)、使用領域別(臨床、研究)、用途別(がん、希少疾患、遺伝子疾患、生殖医療、その他)、エンドユーザー別(学術・研究機関、製薬・バイオテクノロジー企業、臨床・診断ラボ、その他)、地域別、競合他社比較


Next Generation Sequencing Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits), By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing), By Usage Area (Clinical, Research), By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others), By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others), By Region and Competition

次世代シーケンシングキット市場は、予測期間中に目覚ましい成長を遂げると予測されています。これは、iSeq 100システムやIon Gene Studio S5を使用した、より優れた検査技術など、NGSプラットフォームの進歩が世... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2023年8月1日 US$4,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
111 英語

 

サマリー

次世代シーケンシングキット市場は、予測期間中に目覚ましい成長を遂げると予測されています。これは、iSeq 100システムやIon Gene Studio S5を使用した、より優れた検査技術など、NGSプラットフォームの進歩が世界中で進んでいるためと考えられます。同様に、NGSベースの診断検査に対する規制や償還のシナリオが改善されつつあることも、長年にわたる市場の成長をさらに促進するものと思われる。さらに、癌の有病率の増加と、癌およびその他の感染症研究における次世代シーケンサーの応用の増加は、予測期間中に大きな成長を生み出すと予想される。さらに、ポータブルシーケンステクノロジーの開発が進むとともに、主要な主要企業や研究機関とのNGSの技術的進歩のための提携や協力関係が拡大していることも、予測期間中の市場の成長を促進すると予想されます。
NGSにおける進歩の高まり
嚢胞性線維症や鎌状赤血球症のような希少遺伝性疾患の診断のためのDNA検査に対する需要の高まりは、年々著しく増加している。さらに、より少ないコストでより迅速な結果を提供できる高度な技術に対する需要の高まりが、予測期間中の次世代シーケンシングキットの世界市場の成長を促進すると予想される。
例えば、2022年1月、スタンフォード医科大学の科学者とその共同研究者が開発した新しい超高速ゲノムシーケンスアプローチは、希少な遺伝病を平均8時間で診断するために使用された。ゲノム配列決定は、目の色から遺伝性疾患まであらゆる情報を含む患者の完全なDNA構成を科学者が見つけるのに役立ち、DNAに根ざした疾患を持つ患者の診断に不可欠である。また、さまざまな種類の疾患と関連するゲノムマッピング・プログラムの増加、遺伝性疾患とその治療法の解明は、予測期間中の市場の成長をさらに促進する。公共、民間、非営利団体も、新規疾患の治療や診断・医療改善のために、この技術に多額の投資を行っている。次世代シーケンサー市場を支える資金提供の増加は、予測期間中のNGSキット市場の需要をさらに高めるでしょう。

慢性疾患の早期発見に対する需要の高まり

がんやその他の感染症の早期治療を成功させるためには、NGS技術が必要です。そのため、結核、髄膜炎菌性疾患などの癌やその他の感染症の有病率の増加は、予測期間中にNGSキット市場の成長を促進すると予想される主要な要因の1つである。例えば、2022年2月に世界保健機関(WHO)が提供したデータによると、がんは世界的な主要死因であり、2020年には約1,000万人の死亡を占めている。そのため、臨床微生物学における分子診断法の利用は近年急速に増加している。次世代シーケンサー(NGS)のような分子診断技術は、核酸の存在を検出することができ、この技術は迅速で、培養で検体を増殖させる必要がない。研究者たちは、次世代シーケンシングのテキストを使用することで、サンプルから直接、異なる疾患を同時に検出することができる。さらに、マイクロアレイのような伝統的な技術をNGS技術に置き換えて迅速に検出することで、NGSキットの需要は今後さらに高まるだろう。例えば、2022年1月、イルミナ・インクとバンダービルト大学メディカルセンター(VUMC)の完全子会社であるNashville Biosciences LLCは、イルミナの次世代シーケンサー(NGS)プラットフォームを使用した大規模ゲノム解析と卓越した臨床ゲノムリソースの確立により医薬品開発を加速するための複数年契約を締結した。

市場セグメンテーション

世界の次世代シーケンシングキット市場は、ワークフロー、シーケンシングタイプ、使用領域、アプリケーション、エンドユーザー、地域別に区分することができます。ワークフローに基づいて、市場はさらにライブラリー調製、クラスター生成、シーケンス試薬キットに区分される。シーケンスタイプに基づくと、市場はWESおよびWGS、ターゲットシーケンス、ロングリードシーケンス、その他のシーケンスに区分される。使用領域に基づき、市場は臨床と研究に二分される。アプリケーションに基づくと、市場はさらに腫瘍学、希少疾患、遺伝性疾患、生殖医療、その他に分類される。エンドユーザー別では、学術・研究機関、製薬・バイオテクノロジー企業、臨床・診断研究所、その他に分類される。地域別では、アジア太平洋、欧州、中東・アフリカ、南米の中で北米が市場を支配している。国別では、米国が世界の次世代シーケンシングキット市場を席巻しており、これは同国における感染症の早期発見に対する需要の増加を背景としている。

最近の進展
- 2021年1月、BGIグループは、サラセミアやその他のヘモグロビン血症の遺伝子診断や一般集団のキャリアスクリーニングに使用されるサラセミア遺伝子検出キットのCEマーク承認を取得した。
- 2020年9月、テモフィッシャーサイエンティフィック社は、Blueprint Medicines社が開発した標的治療薬GAVRETOを投与されたRET融合遺伝子陽性の転移性非小細胞肺がん患者を同定するためのNGSベースのコンパニオン診断検査であるOncomine Dx Target Testの米国FDAによる市販前承認を取得した。

市場参入企業
Agilent Technologies, Inc.、Bio-Rad Laboratories, Inc.、BGI Group.、Creative Biogene.、Danaher.、F. Hoffmann-La Roche Ltd.、Hologic, Inc.、Illumina, Inc.、Oxford Nanopore Technologies plc.、Pacific Biosciences of California, Inc.、PerkinElmer Inc.などは、世界の次世代シーケンスキット市場で事業を展開する主要企業です。
レポートの範囲
本レポートでは、次世代シーケンシングキットの世界市場を、以下に詳述する業界動向に加えて、以下のカテゴリーに分類しています:
- 次世代シーケンスキット市場、ワークフロー別
o ライブラリー調製
o クラスター生成
シーケンス試薬キット
- 次世代シーケンスキット市場、シーケンスタイプ別:
o WESおよびWGS
o ターゲットシーケンス
o ロングリードシーケンス
o その他のシーケンス
- 次世代シーケンシングキット市場:使用領域別
o 臨床
o 研究
- 次世代シーケンシングキット市場:用途別
o 腫瘍学
o 希少疾患
遺伝子疾患
o リプロダクティブヘルス
o その他
- 次世代シーケンスキット、エンドユーザー別
o 学術・研究機関
o 製薬およびバイオテクノロジー企業
o 臨床および診断研究所
o その他
- 次世代シーケンスキット市場:地域別
o 北米
 米国
 カナダ
 メキシコ
欧州
 フランス
 ドイツ
 イギリス
 イタリア
 スペイン
o アジア太平洋
 中国
 インド
 日本
 韓国
 オーストラリア
南米
 ブラジル
 アルゼンチン
 コロンビア
中東・アフリカ
 南アフリカ
 サウジアラビア
 UAE
競合他社の状況
企業プロフィール:次世代シーケンスキットの世界市場における主要企業の詳細分析。
利用可能なカスタマイズ:
TechSci Research社は、与えられた市場データをもとに、企業固有のニーズに応じたカスタマイズを提供します。このレポートでは以下のカスタマイズが可能です:
企業情報
- 追加市場参入企業(最大5社)の詳細分析とプロファイリング

ページTOPに戻る


目次

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Next Generation Sequencing Kits Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
5.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
5.2.3. By Usage Area (Clinical, Research)
5.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
5.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
5.2.6. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.7. By Company (2022)
5.3. Market Map
5.3.1 By Workflow
5.3.2 By Sequencing Type
5.3.3 By Usage Area
5.3.4 By Application
5.3.5 By End User
5.3.6 By Region
6. North America Next Generation Sequencing Kits Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
6.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
6.2.3. By Usage Area (Clinical, Research)
6.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
6.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Next Generation Sequencing Kits Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Workflow
6.3.1.2.2. By Sequencing Type
6.3.1.2.3. By Usage Area
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Next Generation Sequencing Kits Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Workflow
6.3.2.2.2. By Sequencing Type
6.3.2.2.3. By Usage Area
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Next Generation Sequencing Kits Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Workflow
6.3.3.2.2. By Sequencing Type
6.3.3.2.3. By Usage Area
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. Europe Next Generation Sequencing Kits Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
7.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
7.2.3. By Usage Area (Clinical, Research)
7.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
7.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. France Next Generation Sequencing Kits Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Workflow
7.3.1.2.2. By Sequencing Type
7.3.1.2.3. By Usage Area
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. Germany Next Generation Sequencing Kits Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Workflow
7.3.2.2.2. By Sequencing Type
7.3.2.2.3. By Usage Area
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. United Kingdom Next Generation Sequencing Kits Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Workflow
7.3.3.2.2. By Sequencing Type
7.3.3.2.3. By Usage Area
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. Italy Next Generation Sequencing Kits Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Workflow
7.3.4.2.2. By Sequencing Type
7.3.4.2.3. By Usage Area
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Next Generation Sequencing Kits Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Workflow
7.3.5.2.2. By Sequencing Type
7.3.5.2.3. By Usage Area
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. Asia-Pacific Next Generation Sequencing Kits Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
8.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
8.2.3. By Usage Area (Clinical, Research)
8.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
8.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Next Generation Sequencing Kits Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Workflow
8.3.1.2.2. By Sequencing Type
8.3.1.2.3. By Usage Area
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Next Generation Sequencing Kits Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Workflow
8.3.2.2.2. By Sequencing Type
8.3.2.2.3. By Usage Area
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Next Generation Sequencing Kits Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Workflow
8.3.3.2.2. By Sequencing Type
8.3.3.2.3. By Usage Area
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Next Generation Sequencing Kits Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Workflow
8.3.4.2.2. By Sequencing Type
8.3.4.2.3. By Usage Area
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Next Generation Sequencing Kits Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Workflow
8.3.5.2.2. By Sequencing Type
8.3.5.2.3. By Usage Area
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. South America Next Generation Sequencing Kits Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
9.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
9.2.3. By Usage Area (Clinical, Research)
9.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
9.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Next Generation Sequencing Kits Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Workflow
9.3.1.2.2. By Sequencing Type
9.3.1.2.3. By Usage Area
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. Argentina Next Generation Sequencing Kits Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Workflow
9.3.2.2.2. By Sequencing Type
9.3.2.2.3. By Usage Area
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Colombia Next Generation Sequencing Kits Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Workflow
9.3.3.2.2. By Sequencing Type
9.3.3.2.3. By Usage Area
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. Middle East and Africa Next Generation Sequencing Kits Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
10.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
10.2.3. By Usage Area (Clinical, Research)
10.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
10.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Next Generation Sequencing Kits Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Workflow
10.3.1.2.2. By Sequencing Type
10.3.1.2.3. By Usage Area
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Next Generation Sequencing Kits Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Workflow
10.3.2.2.2. By Sequencing Type
10.3.2.2.3. By Usage Area
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. UAE Next Generation Sequencing Kits Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Workflow
10.3.3.2.2. By Sequencing Type
10.3.3.2.3. By Usage Area
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.1.1 Growing advancement in NGS
11.1.2 Growing Demand for Early Detection of Chronic Diseases
11.2. Challenges
11.2.1 Lack of skilled professionals and infrastructure
11.2.2 Stringent Regulations
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Next Generation Sequencing Kits Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.5.1. Agilent Technologies, Inc.
15.5.2. Bio-Rad Laboratories, Inc.
15.5.3. BGI Group.
15.5.4. Creative Biogene
15.5.5. Danaher.
15.5.6. F. Hoffmann-La Roche Ltd.
15.5.7. Hologic, Inc.
15.5.8. Illumina, Inc.
15.5.9. Oxford Nanopore Technologies plc.
15.5.10. Pacific Biosciences of California, Inc.
15.5.11. PerkinElmer Inc.
16. Strategic Recommendations

 

ページTOPに戻る


 

Summary

Next Generation Sequencing Kits market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising advancements NGS platform such as using the iSeq 100 system and Ion Gene Studio S5 in the technology for better testing across the globe. Similarly, the growing improvement of regulatory and reimbursement scenarios for NGS-based diagnostics tests will further drive the growth of the market over the years. Additionally, the growing prevalence of cancer and increasing applications of next-generation sequencing in cancer and other infectious diseases research is expected to create significant growth during the forecasted period. Moreover, the growing development of portable sequencing technologies along with growing partnerships & collaborations for technological advancements in NGS with major key players and research institutes is expected to drive the growth of the market during the forecast period.
Growing Advancements in NGS
Growing demand for DNA testing for the diagnosis of some rare genetic diseases such as cystic fibrosis and sickle cell diseases has significantly increased over the years. Additionally, the growing demand for advanced technology which can provide faster results at less cost is expected to drive the growth of global next generation sequencing kits market during the forecast period.
For instance, in January 2022, a new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators used to diagnose rare genetic diseases in an average of eight hours. Genome sequencing helps scientists to find a patient’s complete DNA makeup which contains information about everything from eye color to inherited diseases and it is vital for diagnosing patients with diseases rooted in their DNA. Also, the growing genome mapping program linked to different types of diseases and understanding inherited disorders and their treatment will further drive the growth of the market during the forecast period. Public, private, and non-profit interests have also invested largely in the technology to treat novel diseases and improve diagnostics and healthcare. Increased availability of funding supported by the next-generation sequencing market will further enhance the demand for the NGS kits market during the forecast period.

Growing Demand for Early Detection of Chronic Diseases

For the successful treatment of cancer and other infectious diseases in the early stage, NGS technology is required. So, the growing prevalence of cancer and other infectious diseases such as tuberculosis, meningococcal diseases, etc is one of the major factors expected to drive the growth of the NGS kits market during the forecast period. For instance, according to the data provided by World Health Organization (WHO) in February 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. So, the usage of molecular diagnostics methods in clinical microbiology has increased rapidly in recent years. Molecular diagnostic technologies such as next-generation sequencing (NGS) can detect the presence of nucleic acids and this technology are quick and doesn’t require specimen growth in culture. The researchers can use next-generation sequencing texts to detect different diseases concurrently and directly from a sample. Additionally, replacing the traditional technologies such as microarrays by NGS technology for fast detection will further enhance the demand for NGS kits over the years. For instance, in January 2022, Illumina Inc. and Nashville Biosciences LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), entered a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinical-genomic resource using Illumina's next-generation sequencing (NGS) platforms.

Market Segmentation

Global Next Generation Sequencing Kits market can be segmented on the basis of workflow, sequencing type, usage area, application, end users and by region. Based on the workflow, the market is further segmented into library preparation, cluster generation, and sequencing reagents kits. Based on sequencing type, the market can be segmented into WES and WGS, targeted sequencing, long read sequencing, and other sequencing. Based on the usage area, the market can be bifurcated into clinical and research. Based on application, the market can be further grouped into oncology, rare diseases, genetic disorders, reproductive health, and others. Based on end users, the market can be grouped into academic and research institutions, pharmaceutical and biotechnology companies, clinical, diagnostic laboratories, and others. Regionally, in terms of region North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. On the basis of country, the United States dominated the global next generation sequencing kits market on account of the increasing demand for early detection of infectious diseases in the country.

Recent Development
• In January 2021, BGI group received the CE mark approval for the Thalassemia Gene Detection Kit which will be used for the genetic diagnosis of thalassemia and other hemoglobinopathy or for general population carrier screening.
• In September 2020, Themo Fisher Scientific received the US FDA premarket approval for the Oncomine Dx Target Test as and NGS based companion diagnostic test to identify RET fusion positive, metastatic non-small cell lung cancer patients receiving GAVRETO which is a targeted therapy developed by Blueprint Medicines.

Market Players
Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BGI Group., Creative Biogene., Danaher., F. Hoffmann-La Roche Ltd., Hologic, Inc., Illumina, Inc., Oxford Nanopore Technologies plc., Pacific Biosciences of California, Inc., PerkinElmer Inc. are some of the leading players operating in the Global Next Generation Sequencing Kits Market.
Report Scope:
In this report, global Next Generation Sequencing Kits market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Next Generation Sequencing Kits Market, By Workflow:
o Library Preparation
o Cluster Generation
o Sequencing Reagents Kits
• Next Generation Sequencing Kits Market, By Sequencing Type:
o WES and WGS
o Targeted Sequencing
o Long Read Sequencing
o Other Sequencing
• Next Generation Sequencing Kits Market, By Usage Area:
o Clinical
o Research
• Next Generation Sequencing Kits, By Application:
o Oncology
o Rare Diseases
o Genetic Disorders
o Reproductive Health
o Others
• Next Generation Sequencing Kits, By End User:
o Academic and Research Institutions
o Pharmaceutical and Biotechnology Companies
o Clinical and Diagnostic Laboratories
o Others
• Next Generation Sequencing Kits Market, By Region:
o North America
 United States
 Canada
 Mexico
o Europe
 France
 Germany
 United Kingdom
 Italy
 Spain
o Asia Pacific
 China
 India
 Japan
 South Korea
 Australia
o South America
 Brazil
 Argentina
 Colombia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Next Generation Sequencing Kits Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Next Generation Sequencing Kits Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
5.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
5.2.3. By Usage Area (Clinical, Research)
5.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
5.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
5.2.6. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.7. By Company (2022)
5.3. Market Map
5.3.1 By Workflow
5.3.2 By Sequencing Type
5.3.3 By Usage Area
5.3.4 By Application
5.3.5 By End User
5.3.6 By Region
6. North America Next Generation Sequencing Kits Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
6.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
6.2.3. By Usage Area (Clinical, Research)
6.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
6.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Next Generation Sequencing Kits Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Workflow
6.3.1.2.2. By Sequencing Type
6.3.1.2.3. By Usage Area
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Next Generation Sequencing Kits Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Workflow
6.3.2.2.2. By Sequencing Type
6.3.2.2.3. By Usage Area
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Next Generation Sequencing Kits Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Workflow
6.3.3.2.2. By Sequencing Type
6.3.3.2.3. By Usage Area
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. Europe Next Generation Sequencing Kits Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
7.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
7.2.3. By Usage Area (Clinical, Research)
7.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
7.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. France Next Generation Sequencing Kits Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Workflow
7.3.1.2.2. By Sequencing Type
7.3.1.2.3. By Usage Area
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. Germany Next Generation Sequencing Kits Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Workflow
7.3.2.2.2. By Sequencing Type
7.3.2.2.3. By Usage Area
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. United Kingdom Next Generation Sequencing Kits Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Workflow
7.3.3.2.2. By Sequencing Type
7.3.3.2.3. By Usage Area
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. Italy Next Generation Sequencing Kits Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Workflow
7.3.4.2.2. By Sequencing Type
7.3.4.2.3. By Usage Area
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Next Generation Sequencing Kits Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Workflow
7.3.5.2.2. By Sequencing Type
7.3.5.2.3. By Usage Area
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. Asia-Pacific Next Generation Sequencing Kits Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
8.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
8.2.3. By Usage Area (Clinical, Research)
8.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
8.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Next Generation Sequencing Kits Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Workflow
8.3.1.2.2. By Sequencing Type
8.3.1.2.3. By Usage Area
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Next Generation Sequencing Kits Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Workflow
8.3.2.2.2. By Sequencing Type
8.3.2.2.3. By Usage Area
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Next Generation Sequencing Kits Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Workflow
8.3.3.2.2. By Sequencing Type
8.3.3.2.3. By Usage Area
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Next Generation Sequencing Kits Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Workflow
8.3.4.2.2. By Sequencing Type
8.3.4.2.3. By Usage Area
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Next Generation Sequencing Kits Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Workflow
8.3.5.2.2. By Sequencing Type
8.3.5.2.3. By Usage Area
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. South America Next Generation Sequencing Kits Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
9.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
9.2.3. By Usage Area (Clinical, Research)
9.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
9.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Next Generation Sequencing Kits Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Workflow
9.3.1.2.2. By Sequencing Type
9.3.1.2.3. By Usage Area
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. Argentina Next Generation Sequencing Kits Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Workflow
9.3.2.2.2. By Sequencing Type
9.3.2.2.3. By Usage Area
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Colombia Next Generation Sequencing Kits Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Workflow
9.3.3.2.2. By Sequencing Type
9.3.3.2.3. By Usage Area
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. Middle East and Africa Next Generation Sequencing Kits Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Workflow (Library Preparation, Cluster Generation, Sequencing Reagents Kits)
10.2.2. By Sequencing Type (WES and WGS, Targeted Sequencing, Long Read Sequencing, Other Sequencing)
10.2.3. By Usage Area (Clinical, Research)
10.2.4. By Application (Oncology, Rare Diseases, Genetic Disorders, Reproductive Health, Others)
10.2.5. By End User (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others)
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Next Generation Sequencing Kits Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Workflow
10.3.1.2.2. By Sequencing Type
10.3.1.2.3. By Usage Area
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Next Generation Sequencing Kits Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Workflow
10.3.2.2.2. By Sequencing Type
10.3.2.2.3. By Usage Area
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. UAE Next Generation Sequencing Kits Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Workflow
10.3.3.2.2. By Sequencing Type
10.3.3.2.3. By Usage Area
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.1.1 Growing advancement in NGS
11.1.2 Growing Demand for Early Detection of Chronic Diseases
11.2. Challenges
11.2.1 Lack of skilled professionals and infrastructure
11.2.2 Stringent Regulations
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Next Generation Sequencing Kits Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.5.1. Agilent Technologies, Inc.
15.5.2. Bio-Rad Laboratories, Inc.
15.5.3. BGI Group.
15.5.4. Creative Biogene
15.5.5. Danaher.
15.5.6. F. Hoffmann-La Roche Ltd.
15.5.7. Hologic, Inc.
15.5.8. Illumina, Inc.
15.5.9. Oxford Nanopore Technologies plc.
15.5.10. Pacific Biosciences of California, Inc.
15.5.11. PerkinElmer Inc.
16. Strategic Recommendations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート

TechSci Research 社の最新刊レポート

本レポートと同じKEY WORD(biotechnology)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/23 10:28

157.74 円

172.13 円

206.60 円

ページTOPに戻る